JP2008515947A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008515947A5 JP2008515947A5 JP2007536066A JP2007536066A JP2008515947A5 JP 2008515947 A5 JP2008515947 A5 JP 2008515947A5 JP 2007536066 A JP2007536066 A JP 2007536066A JP 2007536066 A JP2007536066 A JP 2007536066A JP 2008515947 A5 JP2008515947 A5 JP 2008515947A5
- Authority
- JP
- Japan
- Prior art keywords
- calcitonin
- use according
- substituted
- unsubstituted
- medicament
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- BBBFJLBPOGFECG-VJVYQDLKSA-N calcitonin Chemical compound N([C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N1[C@@H](CCC1)C(N)=O)C(C)C)C(=O)[C@@H]1CSSC[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1 BBBFJLBPOGFECG-VJVYQDLKSA-N 0.000 claims 6
- 102000055006 Calcitonin Human genes 0.000 claims 5
- 108060001064 Calcitonin Proteins 0.000 claims 5
- 229960004015 calcitonin Drugs 0.000 claims 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 5
- 239000003814 drug Substances 0.000 claims 4
- 206010065687 Bone loss Diseases 0.000 claims 3
- 125000000217 alkyl group Chemical group 0.000 claims 3
- 208000001132 Osteoporosis Diseases 0.000 claims 2
- 125000002947 alkylene group Chemical group 0.000 claims 2
- 201000010099 disease Diseases 0.000 claims 2
- 229910052739 hydrogen Inorganic materials 0.000 claims 2
- 239000001257 hydrogen Substances 0.000 claims 2
- 238000004519 manufacturing process Methods 0.000 claims 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 1
- 125000004450 alkenylene group Chemical group 0.000 claims 1
- 125000003545 alkoxy group Chemical group 0.000 claims 1
- 125000003118 aryl group Chemical group 0.000 claims 1
- 125000000732 arylene group Chemical group 0.000 claims 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims 1
- 229960003773 calcitonin (salmon synthetic) Drugs 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 229940124447 delivery agent Drugs 0.000 claims 1
- 229910052736 halogen Inorganic materials 0.000 claims 1
- 150000002367 halogens Chemical class 0.000 claims 1
- 150000002431 hydrogen Chemical class 0.000 claims 1
- 229910052760 oxygen Inorganic materials 0.000 claims 1
- 239000001301 oxygen Substances 0.000 claims 1
- 108010068072 salmon calcitonin Proteins 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0422644.5A GB0422644D0 (en) | 2004-10-12 | 2004-10-12 | Organic compounds |
| PCT/EP2005/010892 WO2006040114A1 (en) | 2004-10-12 | 2005-10-10 | Use of organic compounds |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2008515947A JP2008515947A (ja) | 2008-05-15 |
| JP2008515947A5 true JP2008515947A5 (enExample) | 2009-02-19 |
Family
ID=33443790
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007536066A Pending JP2008515947A (ja) | 2004-10-12 | 2005-10-10 | 有機化合物の使用 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20090048157A1 (enExample) |
| EP (1) | EP1802328A1 (enExample) |
| JP (1) | JP2008515947A (enExample) |
| KR (1) | KR20070061864A (enExample) |
| CN (1) | CN101035556A (enExample) |
| AU (1) | AU2005293802A1 (enExample) |
| BR (1) | BRPI0516872A (enExample) |
| CA (1) | CA2580766A1 (enExample) |
| GB (1) | GB0422644D0 (enExample) |
| MX (1) | MX2007004259A (enExample) |
| RU (1) | RU2007117492A (enExample) |
| TW (1) | TW200628168A (enExample) |
| WO (1) | WO2006040114A1 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2469709C2 (ru) | 2005-11-17 | 2012-12-20 | Новартис Аг | Фармацевтическая композиция |
| AU2010206614B2 (en) | 2009-01-22 | 2015-03-26 | Keybioscience Ag | Treatment for obesity |
| EP2773365B1 (en) * | 2011-11-02 | 2016-07-20 | KeyBioscience AG | Peptide analogs for treating diseases and disorders |
| US9533022B2 (en) | 2011-11-02 | 2017-01-03 | KeyBioscience A/S | Peptide analogs for treating diseases and disorders |
| CN103998052B (zh) | 2011-11-02 | 2016-08-17 | 关键生物科学有限公司 | 用于治疗疾病和紊乱的肽类似物 |
| CN107345965A (zh) * | 2016-05-04 | 2017-11-14 | 广州优迪生物科技有限公司 | 一种同时检测N-MID和β-CTX的双标记时间分辨荧光免疫分析方法 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5629020A (en) * | 1994-04-22 | 1997-05-13 | Emisphere Technologies, Inc. | Modified amino acids for drug delivery |
| GB9108634D0 (en) * | 1991-04-23 | 1991-06-12 | Ciba Geigy | Pharmaceutical compositions |
| EP0726075A1 (en) * | 1995-02-08 | 1996-08-14 | Therapicon Srl | Pharmaceutical non-inorganic saline solutions for endonasal administration |
| IT1282374B1 (it) * | 1996-01-31 | 1998-03-20 | Therapicon Srl | Composizioni farmaceutiche parenterali a base di calcitonine sintetiche a ph controllato con basso indice di dolorosita' |
| CA2369591C (en) * | 1999-04-05 | 2011-06-14 | Emisphere Technologies, Inc. | Disodium salts, monohydrate, and ethanol solvates |
| US7049283B2 (en) * | 2000-12-06 | 2006-05-23 | Novartis Ag | Pharmaceutical compositions for the oral delivery of pharmacologically active agents |
| US20040110170A1 (en) * | 2002-05-18 | 2004-06-10 | The Regents Of The University Of California | Cloning and characterization of calcitonin gene related peptide receptors |
| TW200411053A (en) * | 2002-12-30 | 2004-07-01 | Ind Tech Res Inst | Nucleic acid encoding recombinant salmon calcitionin, expression vector thereof, and method for producing recombinant salmon calcitonin therewith |
-
2004
- 2004-10-12 GB GBGB0422644.5A patent/GB0422644D0/en not_active Ceased
-
2005
- 2005-10-10 EP EP05795076A patent/EP1802328A1/en not_active Withdrawn
- 2005-10-10 KR KR1020077008224A patent/KR20070061864A/ko not_active Withdrawn
- 2005-10-10 RU RU2007117492/14A patent/RU2007117492A/ru not_active Application Discontinuation
- 2005-10-10 CN CNA2005800339490A patent/CN101035556A/zh active Pending
- 2005-10-10 WO PCT/EP2005/010892 patent/WO2006040114A1/en not_active Ceased
- 2005-10-10 JP JP2007536066A patent/JP2008515947A/ja active Pending
- 2005-10-10 CA CA002580766A patent/CA2580766A1/en not_active Abandoned
- 2005-10-10 MX MX2007004259A patent/MX2007004259A/es not_active Application Discontinuation
- 2005-10-10 BR BRPI0516872-4A patent/BRPI0516872A/pt not_active IP Right Cessation
- 2005-10-10 AU AU2005293802A patent/AU2005293802A1/en not_active Abandoned
- 2005-10-10 US US11/577,127 patent/US20090048157A1/en not_active Abandoned
- 2005-10-11 TW TW094135420A patent/TW200628168A/zh unknown